This bill amends various sections of the Minnesota Statutes to enhance the regulatory framework surrounding medical cannabis and the cannabis industry. A significant change is the replacement of the term "commissioner" with "office," reflecting a shift in oversight responsibilities to the Office of Cannabis Management. The bill clarifies the definition of "health care practitioner" and outlines the office's responsibilities, including the registration and oversight of medical cannabis manufacturers, conducting research on therapeutic uses, and ensuring compliance with program requirements. It also introduces guidelines for patient notifications and advertising restrictions, aiming to improve transparency and compliance within the medical cannabis framework.

Additionally, the bill establishes new regulations for cannabis testing and labeling, mandating comprehensive testing for contaminants and updating labeling requirements to include essential product information. It introduces provisions for cannabis microbusinesses and mezzobusinesses, allowing them to purchase a broader range of products and specifying compliance with production and labeling standards. The bill emphasizes consumer protections, including the need for businesses to provide information on impairment effects and safety resources. Overall, these amendments aim to promote accountability, equitable access, and safe practices within Minnesota's cannabis industry.

Statutes affected:
Introduction: 152.22, 152.24, 152.25, 152.26, 152.261, 152.27, 152.28, 152.29, 152.31, 152.32, 152.33, 152.35, 152.37, 342.01, 342.02, 342.12, 342.14, 342.151, 342.22, 342.28, 342.29, 342.30, 342.33, 342.44, 342.46, 342.52, 342.57, 342.59, 342.61, 342.63